Licensed pharmacists authority to initiate, order and administer vaccines and certain medical and laboratory tests; coverage under medical assistance requirement
Impact
If enacted, SF1176 will amend existing statutes, particularly Minnesota Statutes 2022, section 151.01, by defining the expanded roles of pharmacists. This change will facilitate improved access to vaccinations and potentially decrease the burden on other healthcare providers, giving pharmacists a crucial role in managing public health, especially in preventing vaccine-preventable diseases. Moreover, the bill mandates that medical assistance covers vaccines and laboratory tests administered by licensed pharmacists, which may lead to broader healthcare coverage and facilitate pharmacists' integration into primary care settings.
Summary
SF1176 is a bill aimed at expanding the authority of licensed pharmacists in Minnesota, enabling them to initiate, order, and administer vaccines and certain medical and laboratory tests. This legislation seeks to enhance the role of pharmacists in the healthcare delivery system, allowing them to provide essential services, especially in areas of vaccination, which is critical for public health initiatives. The bill outlines specific conditions under which pharmacists can administer vaccines, including compliance with established protocols and collaborative practice agreements with other licensed healthcare providers.
Contention
The bill has sparked discussions among legislators and stakeholders regarding the implications of expanding pharmacists' roles. Proponents argue that allowing pharmacists to administer vaccines will improve access and streamline health services, especially in rural or underserved areas. However, there are concerns regarding the adequacy of training and the potential for pharmacists to overreach in their new responsibilities. Critics emphasize the importance of maintaining rigorous healthcare standards and ensuring that pharmacists are properly trained to fulfill these expanded roles effectively.
Similar To
Licensed pharmacist authority expanded to initiate, order, and administer vaccines and medical and laboratory tests; and medical assistance coverage required.
Licensed pharmacist authority expanded to initiate, order, and administer vaccines and medical and laboratory tests; and medical assistance coverage required.
Pharmacists authorized to prescribe, dispense, and administer drugs to prevent acquisition of human immunodeficiency virus; pharmacists authorized to order, conduct, and interpret laboratory tests necessary for therapy that uses drugs to prevent acquisition of human immunodeficiency virus.
Pharmacists authorized to prescribe, dispense, and administer hydroxychloroquine and ivermectin for preexposure prophylaxis use, postexposure prophylaxis use, or treatment of COVID-19.
Pharmacist authorization to prescribe, dispense, and administer hydroxychloroquine and ivermectin for preexposure prophylaxis use, postexposure prophylaxis use or the treatment of COVID-19
Health occupations: pharmacists; pharmacists to order and administer certain vaccines and laboratory tests and dispense drugs under certain circumstances; allow. Amends secs. 9204, 9206, 17703, 17707, 17708, 17713, 17751 & 17757 of 1978 PA 368 (MCL 333.9204 et seq.) & adds secs. 17724 & 17724a.
Licensed pharmacist authority expanded to initiate, order, and administer vaccines and medical and laboratory tests; and medical assistance coverage required.
Pharmacists authorized to prescribe, dispense, and administer drugs to prevent acquisition of human immunodeficiency virus; pharmacists authorized to order, conduct, and interpret laboratory tests necessary for therapy that uses drugs to prevent acquisition of human immunodeficiency virus.
Pharmacists authorized to prescribe, dispense, and administer hydroxychloroquine and ivermectin for preexposure prophylaxis use, postexposure prophylaxis use, or treatment of COVID-19.
Pharmacist authorization to prescribe, dispense, and administer hydroxychloroquine and ivermectin for preexposure prophylaxis use, postexposure prophylaxis use or the treatment of COVID-19